Etamsylate Injection

What is Etamsylate Injection?
Etamsylate Injection is a synthetic hemostatic agent widely used to prevent and control abnormal bleeding. It helps strengthen capillary walls and improve platelet adhesiveness, thereby reducing blood loss. It is commonly prescribed in surgical procedures, gynecological bleeding, and capillary fragility disorders.
 
Uses of Etamsylate Injection
Prevention and treatment of capillary bleeding
Control of postoperative hemorrhage
Management of menorrhagia (heavy menstrual bleeding)
Supportive therapy in dental, ENT, and ocular surgeries
Used in internal bleeding due to fragile capillaries
Or all other approved indications
 
How Does Etamsylate Injection Work?
Etamsylate works by increasing platelet adhesiveness and improving capillary resistance, which helps reduce bleeding time. It does not directly affect the clotting mechanism but enhances vascular hemostasis by strengthening blood vessel walls.
 
Frequently Asked Questions (FAQs)
Q: Who is a leading manufacturer of Etamsylate Injection in India?
A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of Etamsylate Injection. We produce high-quality sterile hemostatic injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for bleeding control in surgical and medical settings.
Q: What strengths and packaging options does Farbe Firma offer for Etamsylate Injection?
A: We manufacture Etamsylate Injection primarily in the strength of 125 mg/mL. Our standard packaging includes 2 mL ampoules (250 mg). We also offer customizable packaging solutions to meet specific hospital and international market requirements.
Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for Etamsylate Injection export?
A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.
Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Hemostatic Injectables?
A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for Etamsylate Injection. Pharmaceutical companies looking for a reliable partner for sterile bleeding control products can leverage our advanced manufacturing capabilities.
Q: What is the therapeutic indication of the Etamsylate produced by Farbe Firma?
A: Our Etamsylate Injection is a potent hemostatic agent indicated for the prevention and treatment of capillary bleeding in various conditions, including post-operative hemorrhage, menorrhagia (heavy menstrual bleeding), and bleeding due to capillary fragility disorders.
 
📌 Looking for a reliable Etamsylate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for dossier support, registration assistance, and global export supplies.